Paclitaxel drives TREM2 macrophage expansion underlying its inferior therapeutic efficacy compared to Nab-paclitaxel

Journal:

Nature Communications

Published:

2026-02-03

DOI:

10.1038/s41467-026-69060-5

Affiliations:

9

Authors:

16

Go to article

Institutions	Authors	Share
Peking University Health Science Center (PKUHSC), China	6.166667	0.39
State Key Laboratory of Molecular Oncology, China	4.583333	0.29
Cancer Institute and Hospital, CAMS & PUMC, China	2.000000	0.13
Tianjin Medical University Cancer Institute and Hospital, TMU, China	2.000000	0.13
Qilu Hospital of Shandong University, China	1.000000	0.06
Tianfu Jincheng Laboratory, China	0.250000	0.02

Interested in Oncology and Carcinogenesis?